ストックスクリーナーアプリを入手
105.30
0.47%
-0.50
アフターアワーズ：
105.30
Haemonetics Corp (HAE) 最新ニュース
Haemonetics (NYSE:HAE): A Quality Investing Candidate Built on Durable Fundamentals - ChartMill
Haemonetics Corporation (HAE) Stock Price, News, Quote & History - Yahoo! Finance Canada
HAE6089008 Bond Profile: Coupon and Redemption - TradingView
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance
Haemonetics (HAE) Following Margin Expansion Narrative Looks Fairly Valued - simplywall.st
Haemonetics (HAE) Could Be 66% Undervalued After Margin Expansion Focus - Yahoo Finance
HAE - Finviz
Haemonetics Stock Price Forecast. Should You Buy HAE? - StockInvest.us
Haemonetics stock hits 52-week high at 109.6 USD By Investing.com - Investing.com South Africa
Haemonetics Shares Rise After Citigroup Upgrade - marketscreener.com
HAE Upgraded by Citigroup -- Price Target Raised to $123 - GuruFocus
Haemonetics stock hits 52-week high at 109.6 USD - Investing.com
Haemonetics stock upgraded at Bank of America (HAE:NYSE) - Seeking Alpha
Citigroup Upgrades Haemonetics to Buy From Neutral, Adjusts Price Target to $123 From $92 - Yahoo Finance
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics - GlobeNewswire
Orchestra BioMed Obtains $6.1 Million Milestone Payment From Haemonetics' Acquisition of Vivasure - Yahoo Finance
Haemonetics (HAE) Stock Dropped, So What Is Driving Attention Now? - simplywall.st
Q1 2027 Haemonetics Corp Earnings Call Transcript - GuruFocus
Haemonetics Corporation (HAE) Peer Comparison – Compare with Others - Value Research
HAE Maintained by Raymond James -- Price Target Raised to $125 - GuruFocus
Haemonetics Corporation (HAE) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Haemonetics (HAE) Stock Looks Reasonable On Cash Flow But Rich On Earnings - simplywall.st
Haemonetics (HAE) Q1 2027 Earnings Call Transcript - AOL.ca
Winners And Losers Of Q2: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
HAE Maintained by Baird -- Price Target Raised to $119.00 - GuruFocus
Haemonetics grows recurring revenues with plasm... - Pluang
Robert W. Baird Issues Positive Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
Haemonetics: Worth Speculating On This Recurring Medtech Plasma Model (NYSE:HAE) - Seeking Alpha
26,280 Shares in Haemonetics Corporation $HAE Acquired by Nierenberg Investment Management Company LLC - MarketBeat
Aurora Investment Counsel Acquires New Position in Haemonetics Corporation $HAE - MarketBeat
Haemonetics stock hits 52-week high at 106.64 USD By Investing.com - Investing.com South Africa
HAE Maintains by Barrington Research -- Price Target Raised to $118 - GuruFocus
HAEMONETICS CORP : BARRINGTON RESEARCH RAISES TARGET PRICE TO $118 FROM $95 - Bitget
Haemonetics stock hits 52-week high at 106.64 USD - Investing.com
Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating - marketscreener.com
Haemonetics Shares Hit New 52-Week High: What's Happening? - Sahm
Is Haemonetics’ (HAE) ESOP Shelf Move Reframing Its Balance Between Growth Investment and Shareholder Dilution? - simplywall.st
Haemonetics Corp (HAE) Shares Surge 15.9% -- What GF Score of 85 Tells Investors - GuruFocus
HAE Maintained by BTIG -- Price Target Raised to $110 - GuruFocus
Haemonetics (HAE) Stock Climbs As Analysts Hike Price Targets - StocksToTrade
Form 8K Haemonetics Corp For: 18 August By Investing.com - Investing.com Australia
Haemonetics Jumps as Investors Cheer Raised Fiscal 2027 Outlook - Quiver Quantitative
2.75%
大文字化:
|
ボリューム (24 時間):